Rong Qiu

Rong Qiu

Auto-generated profile, based on publicly available information

Rong Qiu

Institute of Health Sciences, Shanghai Institutes for Biological Sciences, CAS

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
XYXiang Yu
Xiang Yu
LWLi Wang
Li Wang
ZHZhijun Han
Zhijun Han
CYChao Yao
Chao Yao
RQRong Qiu
Rong Qiu
YTYuanjia Tang
Yuanjia Tang
Summary: It is well known that some pathogenic cells have enhanced glycolysis, the regulatory network leading to increased glycolysis are not well characterized. Here, we show that pathogenic T H 17 cells specifically upregulate glycolytic pathway genes compared to homeostatic T H 17 cells. Bioenergetic assay and metabolomics analyses indicate that pathogenic T H 17 cells are highly glycolytic compared to nonpathogenic T H 17 cells. Chromatin landscape analyses demonstrate T H 17 cells in vivo show distinct chromatin states, and pathogenic T H 17 cells show enhanced chromatin accessibility at glycolytic genes with NF-kB binding sites. Mechanistic studies reveal that TGF-β1 signaling induces T H 17 cell chromatin remodeling and represses c-Rel-mediated glycolysis. A miR-21-Peli1 -c-Rel loop was further identified to be essential for glycolysis of pathogenic T H 17 cells. These findings extend our understanding of the regulation T H 17 cell glycolysis in vivo and provide insights for future therapeutic intervention to T H 17 cell mediated autoimmune diseases.